Navigation Links
Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
Date:9/4/2007

CALGARY, Sept. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) ("Oncolytics") today announced that it has been granted U.S. Patent 7,264,798 entitled "Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus." The claims describe a method of using reovirus to prevent Ras-activated cancers from developing drug resistance to chemotherapeutic agents.

"Recent research conducted by the U.S. National Cancer Institute (NCI) and Cornell University demonstrated that administering reovirus in combination with various chemotherapeutic agents potentiates, or enhances tumour-killing, thus preventing the cancer cells from developing drug resistance," said Dr. Matt Coffey, Chief Scientific Officer. "This patent complements the combination REOLYSIN(R) and chemotherapy clinical program that we are pursuing in the U.K."

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This news release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including among others, the Company's belief as to the importance of the issuance of this patent, the safety and efficacy of the reovirus, the Company's expectations as to the potential applications of the patented technology and other statements relating to anticipated developments in the Company's business and technologies, involve known and unknown risks and uncertainties that could cause the Company's
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...LE, Md., Nov. 20 Novavax...s priced an underwritten public offering of 6,800,...ublic of $3.30 per share. The approximately $21 m...riting discounts and commissions, will be used for...P-based vaccines, internal research and developmen...
(Date:11/19/2009)...d like to be able to charge their cell phones and ...en. A recent discovery made by UC San Diego engine...itors that could do just this. , In recent rese...hakar Bandaru, a professor in the UCSD Department ...h graduate student Mark Hoefer, have found that ar...
(Date:11/19/2009)... Nov. 19 NeoStem, Inc. (...t the following letter to its shareholders, discus...9, of China Biopharmaceuticals Holdings, Inc. (CHB... in the People,s Republic of China. The merger giv...re Pharmaceutical Co. Ltd., CHBP,s primary operati...
(Date:11/19/2009)... Top LASIK surgeons and recognized refractive...SIK Surgeons made brought their fellow surgeons up...ection surgery, cataract surgery, and ophthalmolog...ademy of Ophthalmology (AAO) annual meeting in San... Shachar Tauber, Dr. David Huang, MD, Dr. Randy Ep...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Nanotube defects equal better energy and storage systems 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9
...l to Make Soyfoods Even Healthier , , ST. LOUIS, ...of healthcare professionals believe soy to be bene...gricultural biotechnology as a method to make food...indings come from the Healthcare Professional Bio...sored by the United Soybean Board (USB) and conduc...
...manufacturing, Selexis is now offering a portfolio...rotein drugs with added characterization services ...iotechnology company offering technologies and ser...e stable production cell lines announced today an ...t segment. Under the new program, Selexis will of...
...f., March 31 Sigma-Aldrich (Nasdaq: SIAL ) to...services and oligonucleotides to Gene Oracle, an i... of the agreement, Sigma-Aldrich will be the exclu...Oracle, and the two Companies will engage in co-ma...their expert gene synthesis services ( http://ww...
Other Biology Technology:Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 2Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products 3Selexis Launches Biosimilar Cell Line Development Program 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 2Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform 3
(Date:11/23/2009)...2009 - The time of day matters to forest trees dea...ed by a research team led by Professor Malcolm Cam...incipal for research and colleagues in the departm...campus. , Capitalizing on their previous work ...rch team examined how poplar trees use their 45,00...
(Date:11/23/2009)...swine vaccine available for the H1N1 virus has bee... virus. The vaccination marks the first time vacci...e pandemic flu., Iowa State University,s Hank Ha...accine this summer and has been shipping preventiv...inois for several weeks., The latest vaccines we...
(Date:11/23/2009)... studies reveal in unprecedented detail how the ri...new proteins and guide them toward their destinati... dynamics flexible fitting (MDFF) to examine the i...cular partners. , The first study, in Proceedi... the intimate signaling between the ribosome and a...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 1FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 2FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 3FDA Advisory Committee Votes in Favor of SAPHRIS 28R 29 28asenapine 29 for Acute Bipolar I Disorder and Acute Schizophrenia 4800 4VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 1VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 2VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE 4799 3Americans Spend Billions on Alternative Medicine 53255 1Americans Spend Billions on Alternative Medicine 53255 2Americans Spend Billions on Alternative Medicine 53255 3
...vania scientists studying macrophages, the biologi...t and destroy foreign or dying cells, have discove...nd and foe. , The paper appears as the cover art...l Biology. , The knowledge suggests new ways scie... are the root cause of the many inflammatory disea...
...el of social co-operation, the ant world is riddle...e way to the top, according to scientists from the...e always been thought to work together for the ben.... But Dr Bill Hughes from Leeds Faculty of Biologi...lusion. , With Professor Jacobus Boomsma from the...
...rush to produce corn-based ethanol as a fuel alter..., increasing a Dead Zone that kills fish and aquat...ia researcher Simon Donner. , In the first study ...ersity of Wisconsin quantify the effect of biofuel...n a waterway. Their findings will appear in the Ma...
Other Biology News:Policing cells demand ID to tell friend from foe, say University of Pennsylvania cell engineers 2Royal corruption is rife in the ant world 2US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2
...s designed to aid sequence analysis of long DNA fr...S) of M13 phage vectors (mp18/19) or pUC-related p...used to create nested unidirectional deletions in ...rimer binding site on the vector closer to the seq...
...of Freezerworks Unlimited includes 2 clients and s...me labs and facilitates the sharing of freezers by...information. Network Client/Server version f...itor with 256 colors; OS 8.6 & OS 9.x Works for a...
Rabbit Anti-Human PAC1 Antibody, Unconjugated from ABR-Affinity BioReagents
Microplate Rack for Standard Plates from Thermo Scientific
Biology Products: